Diptaman Chatterjee

Rush University, Chicago, IL, United States 
Neuroscience, neurodegeneration, therapeutic development, Parkinson's disease, alzheimer's disease, alpha-synuclein, misfolded protein disorders
"Diptaman Chatterjee"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chatterjee D, Kordower JH. (2019) Immunotherapy in Parkinson's disease: Current status and future directions. Neurobiology of Disease. 104587
Chatterjee D, Sanchez DS, Quansah E, et al. (2019) Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy. Journal of Parkinson's Disease
Chatterjee D, Bhatt M, Butler D, et al. (2018) Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease model. Npj Parkinson's Disease. 4: 25
See more...